Associations of , , , and LINE-1 methylation, measured in saliva, with waist circumference, body mass index, and percent body fat in mid-childhood by unknown
RESEARCH Open Access
Associations of LEP, CRH, ICAM-1, and LINE-
1 methylation, measured in saliva, with
waist circumference, body mass index, and
percent body fat in mid-childhood
Jocelyn Dunstan1*, Joseph P. Bressler2, Timothy H. Moran3, Jonathan S. Pollak2, Annemarie G. Hirsch4,
Lisa Bailey-Davis4, Thomas A. Glass1 and Brian S. Schwartz2,4
Abstract
Background: Genetics explains a small proportion of variance in body mass index at the population level.
Epigenetics, commonly measured by gene methylation, holds promise for understanding obesity risk factors
and mechanisms.
Methods: Participants were 431 adolescents aged 10–15 years. BMI z-score, waist circumference z-score, and
percent body fat were measured. Saliva samples were collected and methylation of promoter regions of four
candidate genes or sequences (LEP, ICAM-1, CRH, and LINE-1) were measured in 3–4 CpG sites each. Linear
regression was used to identify associations of methylation with obesity-related outcomes.
Results: After adjusting for age, in sex-stratified analysis, the three obesity-related outcomes were negatively
associated with LEP methylation in obese boys only. There were no associations of methylation of the other
genes or sequences and the obesity-related outcomes.
Conclusions: Our results are consistent with prior studies that reported sex differences in associations of
obesity-related outcomes with LEP methylation, and also as would be expected in adipose tissue, the source
of circulating leptin. The findings suggest that saliva might be an acceptable tissue for epigenetics studies in
adolescents.
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Background
Childhood obesity is a major public health concern
worldwide [1]. Obese children and adolescents may
experience physical and psychological consequences,
such as increased risk for the development of diabetes
and cardiovascular diseases as well as low self-esteem
[2]. Childhood obesity often persists into adulthood
[3], with associated increased risk of premature
mortality [4].
In the USA, the prevalence of obesity in 2013–2014 for
children and adolescents between 6–11 and 12–19 years
of age was 19.6 and 20.6%, respectively [5]. The prevalence
differed by race/ethnicity, with evidence of highest
prevalence in the Hispanic/Latino population [5, 6].
Since genetic variation explains only a small proportion
of the variation in BMI [7, 8], a growing number of
studies have investigated the role of epigenetic factors.
Gene expression is partially regulated by epigenetic
mechanisms, which are changes that are not due to
alterations of the DNA sequence [9]. Epigenetic mecha-
nisms include DNA methylation, histone modification,
and DNA-binding proteins [10].
Epigenetic changes in genes related to stress and appetite
have been studied as predictors of satiety, appetite, and
obesity [11]. In epidemiological studies, DNA methylation
is the most frequent epigenetic mechanism studied
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because it can be measured in surrogate tissues in
large populations in quantitative assays. The use of
surrogate tissues requires evaluation like that pre-
sented herein. DNA methylation occurs primarily at
cytosine within cytosine-guanine dinucleotides (CpG),
and it affects gene expression by modifying the degree
to which the DNA is accessible to promoters or
suppressors [12].
This research evaluated associations between DNA
methylation, measured in saliva samples, and anthropo-
metric and body composition measurements (hereafter
called “obesity-related measures”) in 431 adolescents
between 10 and 15 years of age. Associations were also
examined in relation to medical information in elec-
tronic health records (EHR), dietary and physical activity
behavioral questionnaires from the child, and parental
BMI. We measured methylation in 3–4 CpG sites in the
promoter regions of three candidate genes selected on
the basis of different biological pathways that are
involved in obesity: leptin (LEP, associated with appetite
and fat metabolism [13]), corticotropin-releasing hor-
mone (CRH, stress and appetite [14]), and intracellular
adhesion molecule (ICAM-1, inflammation [15]). In
addition, methylation in the LINE-1 gene sequence was




Subjects were identified, recruited, and enrolled during
the summer months of 2013 and 2014. First, target
communities were identified according to three criteria:
(1) located within the Geisinger Clinic’s 45-county
catchment area; (2) had at least 75 primary care pa-
tients aged 10–15 years, the target age range for the
study; and (3) it fell into one of the four cells of the
community selection table, defined by having: (a) high
or low proportions of overweight (BMI for age/sex
percentile ≥85th) and obese (BMI for age/sex percentile
≥95th) children and (b) community environments con-
sidered obesogenic or obesoprotective based on com-
munity socioeconomic deprivation, population density,
and physical activity diversity [16]. For the third criter-
ion, environmental variables and community over-
weight/obesity prevalence were each first divided into
quintiles along a gradient of obesogenic to obesoprotec-
tive environments and high to low overweight/obesity
prevalence. Then, communities were selected in the first
or fifth quintile for each in four strata: (1) obesogenic
environment, high prevalence; (2)obesogenic environ-
ment, low prevalence; (3) obesoprotective environment,
high prevalence; and (4) obesoprotective environment,
low prevalence.
Children and adolescents (hereafter “children”) were
first identified using EHR to obtain age and address
information. A pre-notification letter was next sent that
provided the parent the option of opting out of the
study. If this was not returned within 10 days, the house-
hold was next contacted by phone to enroll the child
and one parent in the study. If the household agreed to
participate, a home visit was scheduled. At each house-
hold visit, one parent/guardian and one child between
10 and 15 years of age were enrolled. A total of 431
dyads were enrolled from 28 communities that included
9 boroughs, 11 townships, and 8 census tracts ranging
(median) from 7 to 28 (14.5) enrolled children per
community.
Each household received a $30 gift card for the time
and effort. In 2013, 210 child-parent dyads were enrolled
(22.2% participation rate) and in 2014, 222 additional
dyads participated (14.8% participation rate). The most
common reasons for lack of participation included
passive refusal after 18 phone calls, active refusal after
telephone contact, and incorrect telephone number [17].
The study was approved by the Institutional Review
Boards at both the Geisinger Health System and the
Johns Hopkins Bloomberg School of Public Health.
Data collection
During the in-home visit, trained research staff mea-
sured height using a portable stadiometer (model seca
213, seca North America, Inc.); weight and percent body
fat (PBF, three times) with a calibrated portable digital
scale with tetrapolar bioelectrical impedance analysis
(model TBF-300A, TANITA Corporation of America,
Inc., Arlington Heights, IL); and waist circumference
(WC, three times) with a measuring tape. The measure-
ments were taken following the NHANES anthropomet-
ric procedures manual [18]. Shoes and socks were
removed prior to height and weight measurements, and
children were asked to empty their pockets and remove
heavy layers of clothing. The waist circumference was
measured with one shirt layer and at the hip bone level.
Participants were asked to cross their arms and place
them at their opposite shoulders, and the measurement
was taken during normal expiration.
Height and weight were used to estimate the body
mass index (BMI, kg/m2). Age- and sex-specific BMI z-
scores (hereafter BMI-z) were created based on national
standards [19]. Similarly, measured WC mean values
were used to create WC z-scores (WC-z) as previously
reported [20]. Demographic information was obtained
from a parent during the initial telephone contact.
During the home visit, the child completed a self-
administrated questionnaire about food and physical
activity environments and habits, as previously reported
[17]. Data from EHR included use of Medical Assistance
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for health insurance (as a proxy measure of low family
socioeconomic status (SES)), medication history (e.g.,
antibiotics, stimulants, antidepressants, and anti-anxiety
agents), and selected diagnoses (e.g., asthma, diabetes,
food allergies, other allergies, and mental health [ICD-9
codes 290.x to 319.x]). These were created as ever vs.
never variables and evaluated in regression models one
at a time.
Epigenetic measures
From each child, a saliva specimen was collected during
the home visit using the Oragene-DISCOVER kit (OGR-
500, DNA Genotek, Inc, Ontario, Canada). DNA bisulfite
conversion was accomplished using EZ DNA Methylation
Kits (Zymo Research) by following the manufacturer’s
manual. Briefly, 0.5–1.0 μg of genomic DNA was first
mixed with 5 μl of M-Dilution Buffer and incubated at
37 °C for 15 min and then mixed with 100 μl of CT Con-
version Reagent. Mixtures were incubated in a thermocy-
cler with 16 thermal cycles at 95 °C for 30 s and 50 °C for
1 h. Bisulfite-converted DNA samples were loaded onto
96-column plates provided in the kit for desulfonation
and purification. The concentration of eluted DNA was
measured using a NanoDrop 1000 spectrometer.
DNA methylation was quantitated using bisulfite-PCR
and pyrosequencing using the following kits from
Qiagen: ICAM1_02 for ICAM-1, CRH_01 for CRH,
LEP_01 for LEP, and NOS3_02 for LINE-1. Sequencing
was conducted using Pyromark Q24, and percent methy-
lation was computed using the Pyromark Q24 Software
v.2 in CpG mode. Details about the location of the mea-
sured CpG sites are in the online supporting information
(Additional file 1: Table S1).
Statistical analysis
The primary goal of the analysis was to evaluate associa-
tions of obesity-related measures (BMI-z, WC-z, and
PBF) with DNA methylation at each CpG site and for
the mean of that gene across sites while adjusting for
potential confounding by age. Before performing the
analysis, we considered the causal ordering of DNA
methylation and obesity [21]. These are complex rela-
tionships that may involve bi-directional influences.
However, we hypothesized that LINE-1, CRH, and
ICAM-1 were predominantly antecedent contributors to
weight gain. Thus, for these loci, we modeled obesity as
the outcome with methylation as the predictor. In
contrast, for LEP, because obesity is known to influence
leptin levels and triggers leptin resistance [21], we
modeled LEP methylation as the outcome with obesity
as the predictor. Analysis was performed using Stata 14
(StataCorp LP, College Station, TX).
Summary statistics were first examined for all obesity-
related measures and for all DNA methylation by CpG
site and as overall gene means, for all children com-
bined, and then for boys and girls separately. Associa-
tions were evaluated using linear regression, first for all
children combined, and then separately for boys and
girls in a single model with a cross-product term be-
tween sex and the variable of interest. The model was
adjusted for the child’s age (centered) and evaluated
non-linearity by inclusion of a quadratic term for age.
Linear regression beta coefficients, standard errors, and
p values are reported.
Variables were also created from the child question-
naire, previously described [17] and evaluated in associ-
ation with DNA methylation (three genes and one gene
sequence) or obesity-related outcomes (as confounders
of the relation with LEP methylation). The questions
were about home environment and the child’s dietary
and physical activity behaviors. Several questionnaire
items were combined to create summary scores [22], as
continuous variables if distributions were not highly
skewed, or using tertiles if they were. Variables were only
retained in the model if they had an associated p value
<0.05 when included in the model and if the beta coeffi-
cient for the primary predictor variable changed by more
than 10% when the new variable was included. BMI was
modeled as a continuous variable and also as indicator
variables for overweight (BMI-z between 85th and 95th
percentile) and obesity (BMI-z over the 95th percentile).
Reported results are not corrected for multiple
comparisons. Normality of residuals, homoscedas-
ticity, independence (collinearity), and sensitivity to
outliers were evaluated in the final model by examin-
ation of variance inflation factors and added variable
plots. A p value <0.05 was considered statistically
significant.
Results
Description of the study subjects
Of the 431 children included in the study, 210 were
boys and 221 were girls. Their mean age was just
under 13 years for boys and girls, 93% were Caucasian,
35% received Medical Assistance for health insurance,
and sizable portions were overweight or obese
(Table 1). The large majority of participating parents
were mothers with mean BMI values approaching
30 kg/m2.
Methylation levels at all CpG sites measured in the
CRH and ICAM-1 genes were low in both boys and girls
with minimal variation (online supporting information,
Additional file 2: Table S2). Mean methylation levels in
LINE-1 were high for both boys and girls, and there
were no differences by sex or obesity status. Methylation
levels of LEP differed by CpG site; there were also
significant differences between boys and girls (Additional
file 2: Table S2).
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Associations of obesity-related measures and LEP
methylation
Obesity was consistently and strongly associated with
LEP methylation and that association varied by sex
(Table 2 and Fig. 1). Parental BMI was associated with
both LEP methylation and obesity-related outcomes and
changed the primary association more than 10%; there-
fore, it was retained in all subsequent models. In con-
trast, inclusion of EHR or child questionnaire-derived
variables in the models did not identify any as significant
predictors of LEP methylation. These variables also did
not change relations of any obesity-related measure with
LEP methylation.
The associations in the regression models were pri-
marily driven by obese boys (Fig. 1). This was confirmed
when the regression models were repeated in boys only,
with indicators for overweight and obesity as the
primary predictors (Table 3). The beta coefficients for
obesity were negative and relatively large, indicating
that obesity in boys was associated with lower LEP
methylation levels.
Associations of CRH, ICAM-1, and LINE-1 methylation with
obesity-related outcomes
Linear regression was next used to evaluate associations
of methylation levels in CRH, ICAM-1, and LINE-1 in
Table 1 Summary statistics of participating children and parents
All Males Females
Children
N (%) 431 (100) 210 (48.72) 221 (51.28)
Mean age, years (SD) 12.86 (1.70) 12.77 (1.64) 12.93 (1.75)
Race/ethnicity
Caucasian (%) 395 (92.72) 187 (90.78) 208 (94.55)
Non-Caucasian (%) 31 (7.28) 19 (9.22) 12 (5.45)
Body mass index, kg/m2
<85th percentile (%) 285 (65.67) 135 (64.29) 150 (66.96)
85th to 95th percentile (%) 71 (16.36) 32 (15.24) 39 (17.41)
≥95th percentile (%) 78 (17.97) 43 (20.48) 35 (15.62)
Waist circumference z-score (%) 0.48 (0.92) 0.55 (0.95) 0.41 (0.89)
Percent body fat (SD)a 22.96 (11.31) 19.73 (11.18) 26.01 (10.57)
Received medical assistance (%) 154 (35.48) 82 (39.05) 72 (32.14)
Parents
N (%) 416 (100) 60 (14.42) 356 (85.58)
Mean age, years (SD) 42.62 (8.22) 47.30 (8.40) 41.83 (7.93)
Body mass index, kg/m2 (SD) 29.17 (7.48) 29.73 (5.78) 29.08 (7.73)
This table shows characteristics of our sample stratified by sex
aPercent body fat was available for only 430 children
Table 2 Stratified analysis (boys and girls) of adjusted associations for leptin methylation at four CpG sites and for overall mean as
outcome and the three obesity-related measures as primary predictors
Predictor LEP methylation (dependent variable)





















































































Ordinary least squares regression models were adjusted for age and parental BMI
BMI-z body mass index z-score, WC-z waist circumference z-score, PBF percent body fat
P values: **0.001 ≤ P < 0.01; *0.01 ≤ P < 0.05
§P value for interaction term between leptin methylation and sex
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relation to the three obesity-related outcomes. There
were no associations for CRH or LINE-1 with any
obesity-related measure for either boys or girls (results
not shown). For ICAM-1, methylation of CpG1 was
inversely associated with PBF in boys; mean methylation
was inversely associated with WC-z in boys; and the cross
product p value between CpG1 and sex was significant for
all three obesity-related outcomes, with opposite direc-
tions of associations for boys and girls (online supporting
information, Additional file 3: Table S3, Additional file 4).
Inclusion of EHR variables (e.g., SES, child medication
history, child diagnoses), child questionnaire-derived
variables, and parental BMI in these models did not
substantively change associations or inferences.
Discussion
This is the first large study to investigate associations
between DNA methylation in candidate genes measured
in saliva, related to appetite, stress, and inflammation,
and obesity-related outcomes in children and adoles-
cents. Three genes were chosen because they are im-
portant regulators of biological pathways involved in
obesity: CRH (stress), ICAM-1 (inflammation), and LEP
(appetite). A strong association was found between in-
creased methylation in the LEP promoter region in boys
but not in girls. No associations were detected with
methylation in the other genes, which had low absolute
values with little variation, perhaps because of the CpG
sites that were measured.
Several important confounding variables were evalu-
ated, including child self-reported information on diet
and physical activity, and medical history and medica-
tions from EHR data. None of these variables were asso-
ciated with LEP methylation levels. Analysis of EHR
medication data was of interest, for example, because we
have previously reported that stimulants were associated
with BMI trajectories in children [23], and we were
interested to evaluate whether this association may be
mediated through LEP methylation, as both circulating
leptin and stimulants affect appetite [7, 24].
Parental BMI was associated with both LEP methyla-
tion and the obesity-related measures. There is consist-
ent with prior evidence that parental BMI should be
strongly associated with child BMI [3]. Most of the
parents in the study were female (86%), and some stud-
ies have looked at epigenetic changes passed by mothers
Fig. 1 LEP methylation in each CpG site, by sex, for lean, overweight, and obese children. a CpG-1, b CpG-2, c CpG-3, and d CpG-4
Table 3 Adjusted associations for LEP methylation in boys with overweight and obese status as primary predictor
Obesity status
(predictors)











Overweight 0.373 (1.140) 0.730 (0.495) 0.850 (0.719) 1.207 (1.243) 0.790 (0.768)
Obese −2.822** (0.993) −1.507*** (0.432) −2.149*** (0.627) −3.961*** (1.080) −2.610*** (0.666)
Models adjusted for age and parental BMI
P values: ***P < 0.001; **0.001 ≤ P < 0.01; *0.01 ≤ P < 0.0
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to children, for example by measuring LEP methylation
in placental tissues [25]. We only had information about
parental BMI at the date of the home visit, and no infor-
mation about history of maternal hypoglycemia or gesta-
tional diabetes, which have been proposed as causal
pathways to change DNA methylation [26].
LEP is a polypeptide released from adipocytes that
feeds back to neurons in the hypothalamus and other
brain regions to suppress appetite. The regulation of
LEP is due, in part, to methylation at its prompter. Our
finding that obese boys had lower levels of LEP methyla-
tion would be expected to result in higher levels of lep-
tin in serum and appetite suppression (but rodent
models have provided some results inconsistent with this
finding [27]). It should be noted that changes in LEP
promoter methylation are not restricted to adipocytes; in
addition to our study on saliva, similar findings have
been reported using DNA from blood samples of chil-
dren [13]. Another study reported a negative correlation
between LEP methylation, measured in blood, and BMI
in 73 persons with severe obesity, although no associa-
tions were found using subcutaneous or visceral adipose
tissue [28]. This absence of specificity in adipocytes sug-
gests that promoter methylation in the LEP gene could
be a potential biomarker for LEP resistance from several
cell types (possibly because those other cell types, such
as leukocytes, are also involved in appetite regulation).
Sex differences in the methylation levels of LEP have
been reported previously. In a study conducted in
infants (50 girls, 70 boys), higher BMI was negatively
correlated with LEP methylation in boys [29]. In the
Dutch cohort of mothers who suffered famine during
War Word II, famine exposure was associated with LEP
methylation only in the male children compared to
siblings of the same sex without famine exposure (the
sample size was 311 children exposed and 311 control
siblings) [30]. A possible explanation for the sex differ-
ences could be due to the involvement of leptin in sexual
maturation. Leptin is an important hormone in female
development [31]: similar to estrogens and progesterone,
serum leptin levels change across the menstrual cycle
[32]. Associations between LEP promoter methylation
and obesity in females may be difficult to discern
because of the influence of sex hormones on DNA
methyltransferases, the enzymes responsible for DNA
methylation [33]. Prominent changes in hormone levels
occur during puberty, which was likely to be occurring
in many of our 10–15-year-old children.
One of the limitations of this study is that it was cross-
sectional, so temporal relations of epigenetic measures
and obesity-related outcomes cannot be discerned. An-
other limitation is that only four genes or gene sequences
were evaluated, in contrast to epigenome-wide ap-
proaches, which are the current standard in epigenetic
research [34]. Budget limitations precluded epigenome-
wide measurements in our large sample. Finally, we did
not have circulating leptin measurements, which would
have been very helpful in assessing the biological plausibil-
ity of our findings.
Conclusions
We found an association between DNA methylation in
each CpG site of the gene LEP, measure in saliva, and
obesity-related measures in 431 children aged 10–
15 years old. This association differed by sex and obesity
status, with a much stronger association in obese boys.
No significant associations were observed in the CpG
sites tested for ICAM-1, CRH and LINE-1. The results
suggests that saliva may be a useful surrogate tissue for
large-scale studies of epigenetics in relation to obesity,
particularly in children and adolescents for whom
venipuncture is an obstacle to study participation [35].
Saliva collection is non-invasive and inexpensive, and re-
sults were biologically consistent. Future studies should
focus on the temporality of epigenetic changes in rela-
tion to the onset of obesity.
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